K. Krohn and I. Shuklov
336
The reaction mixture was extracted with diethyl ether (3 ꢀ 50 mL) and the
combined organic layers were dried over MgSO4, filtered, and concentrated.
Purification by silica gel column chromatography (CH2Cl2) gave 5 (0.20 g,
70%) as a colorless oil. Rf ¼ 0.5 (CH2Cl2/MeOH, 98:2). [a]2D0 235.7 (c 0.33,
CHCl3). IR (KBr): 3448, 2924, 2881, 1454, 1400, 1219, 1184, 1113, 1086,
1
1043, 1022, 953; H NMR (500 MHz, CDCl3): 1.88 (dddd, 1H, J4a,2 ¼ 1.4 Hz,
J4a,2 ¼ 3.4 Hz, J4a,3 ¼ 5.7 Hz, Jgem ¼ 17.7 Hz, H-4a), 2.11–2.19 (m, 1H, H-4b),
3.57 (dd, 1H, J6a,5 ¼ 3.1 Hz, Jgem ¼ 11.6 Hz, H-6a), 3.67 (dd, 1H,
J6b,5 ¼ 6.2 Hz, Jgem ¼ 11.6 Hz, H-6b), 4.06 (ddd, 1H, J5,6a ¼ 3.1 Hz,
J5,6b ¼ 6.2 Hz, J5,4b ¼ 11.3 Hz, H-5), 4.61 (d, 1H, Jgem ¼ 12.0 Hz, CH2Ph),
4.78 (d, 1H, Jgem ¼ 12.0 Hz, CH2Ph), 5.11 (t, 1H, J ¼ 1.3 Hz, H-1), 5.77 (dddd,
1H, J2,1 ¼ 1.4 Hz, J2,4a ¼ 1.3 Hz, J2,4b ¼ 4.3 Hz, J2,3 ¼ 10.1 Hz, H-2), 6.03
(dddd, 1H, J3,1 ¼ 1.4 Hz, J3,4b ¼ 1.4 Hz, J3,4a ¼ 5.7 Hz, J3,2 ¼ 10.1 Hz, H-3),
7.28–7.39 (m, 5H, Ph). 13C NMR (125 MHz, CDCl3): 26.0 (C-4), 65.2 (C-6),
65.3 (CAr), 67.2 (C-5), 69.8 (CH2Ph), 94.2 (C-1), 125.4 (C-2), 127.0 (CAr), 127.6
(C-3), 127.7, 128.6, 138.2, 140.1 (4 ꢀ CAr). MS (EI, 70 eV): m/z (%) ¼ 220 (1)
[M]þ, 203 (2) [M-OH], 129 (10) [M-PhCH2]þ, 91 (100), [PhCH2]þ, 77 (60) [Ph]þ.
Benzyl 6-O-tosyl-2,3,4-trideoxy-a-D-glycero-hex-2-enopyranoside (6)
Tosyl chloride (0.26 g, 1.2 mol) was added to the solution of 5 (0.25 g,
1.2 mmol), a catalytic amount of 4-DMAP, and pyridine (0.15 mL, 1.5 mmol)
in dry CH2Cl2 (100 mL). The reaction mixture was stirred at rt for 12 h and
the conversion was monitored by TLC (CH2Cl2/MeOH, 98:2). The reaction
mixture was washed with saturated aqueous NaHCO3 solution and brine.
The combined organic layers were dried over MgSO4, filtered, and concen-
trated. Purification by silica gel column chromatography (CH2Cl2) gave
tosylate 6 (0.40 g, 95%) as a colorless oil. Rf ¼ 0.9 (CH2Cl2/MeOH, 98:2). [a]D20
228.7 (c 0.8, CHCl3). IR (KBr): 3367, 2974, 2891, 1361, 1190, 1176, 1093,
1
1047, 1022, 1003, 991, 966, 949, 814. H NMR (500 MHz, CDCl3): 1.92 (dddd,
1H, J4a,2 ¼ 1.4 Hz, J4a,5 ¼ 3.6 Hz, J4a,3 ¼ 5.7 Hz, Jgem ¼ 17.5 Hz, H-4a), 2.02–
2.10 (m, 1H, H-4b), 2.44 (s, 3H, CH3Ph), 4.03–4.13 (m, 2H, H-6a, H-6b),
4.15–4.20 (m, 1H, H-5), 4.51 (d, 1H, Jgem ¼ 11.8 Hz, CH2Ph), 4.60 (d, 1H,
Jgem ¼ 11.8 Hz, CH2Ph), 5.01 (t, 1H, J ¼ 1.3 Hz, H-1), 5.72–5.76 (m, 1H,
H-2), 5.95–6.00 (m, 1H, H-3), 7.26–7.36 (m, 7H, Ph, Ts), 7.80–7.83 (m, 2H,
Ts). 13C NMR (125 MHz, CDCl3): 21.7 (C-4), 26.2 (CH3), 64.4 (C-5), 69.5
(CH2Ph), 71.4 (C-6), 93.7 (C-1), 125.6 (C-2), 127.6 (C-3), 127.7, 127.8, 128.0,
128.2 (4 ꢀ CAr), 128.4 (CAr, Ts), 133.1, 137.9, 144.8 (3 ꢀ CAr). MS (EI, 70 eV):
m/z (%) ¼ 375 [M]þ (1), 172 [CH3C6H4SO3H]þ (18), 91 [C6H5CH2]þ (100).
Benzyl 4-deoxy-6-O-tosyl-a-D-lyxo-hexopyranoside (7)
A 25-mL three-necked round-bottomed flask, with a magnetic stirrer and
a nitrogen inlet, was charged with the monohydrate of N-methylmorpholin
(0.16 g, 1.3 mmol), water (10 mL), and acetone (10 mL). To this solution was